Nutromics
Extensive clinical validation and deployment are what remain to make it routine, according to University of New South Wales Scientia Professor Justin Gooding.
It is currently conducting an in-human trial of its diagnostic patch.
It is currently conducting clinical studies and expanding its teams in Australia and the US.
His appointment comes ahead of the med tech startup's clinical trials for its continuous molecular monitoring device.
The CMM platform renders real-time, continuous molecular-level insights that help inform dosing decisions.